vs
Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and LIVEPERSON INC (LPSN). Click either name above to swap in a different company.
LIVEPERSON INC is the larger business by last-quarter revenue ($59.3M vs $31.1M, roughly 1.9× LIFECORE BIOMEDICAL, INC. \DE\). LIFECORE BIOMEDICAL, INC. \DE\ runs the higher net margin — -32.1% vs -77.8%, a 45.6% gap on every dollar of revenue. On growth, LIFECORE BIOMEDICAL, INC. \DE\ posted the faster year-over-year revenue change (-4.5% vs -19.0%). LIFECORE BIOMEDICAL, INC. \DE\ produced more free cash flow last quarter ($25.0K vs $-12.0M). Over the past eight quarters, LIFECORE BIOMEDICAL, INC. \DE\'s revenue compounded faster (-0.1% CAGR vs -16.6%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
LivePerson is a global technology company that develops conversational commerce and AI software.
LFCR vs LPSN — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $31.1M | $59.3M |
| Net Profit | $-10.0M | $-46.1M |
| Gross Margin | 25.0% | 73.2% |
| Operating Margin | -9.9% | -68.7% |
| Net Margin | -32.1% | -77.8% |
| Revenue YoY | -4.5% | -19.0% |
| Net Profit YoY | -52.0% | 58.9% |
| EPS (diluted) | $-0.29 | $-9.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $59.3M | ||
| Q3 25 | $31.1M | $60.2M | ||
| Q2 25 | — | $59.6M | ||
| Q1 25 | $35.2M | $64.7M | ||
| Q4 24 | $32.6M | $73.2M | ||
| Q3 24 | $24.7M | $74.2M | ||
| Q2 24 | — | $79.9M | ||
| Q1 24 | $35.7M | $85.1M |
| Q4 25 | — | $-46.1M | ||
| Q3 25 | $-10.0M | $8.7M | ||
| Q2 25 | — | $-15.7M | ||
| Q1 25 | $-14.8M | $-14.1M | ||
| Q4 24 | $-6.6M | $-112.1M | ||
| Q3 24 | $-16.2M | $-28.3M | ||
| Q2 24 | — | $41.8M | ||
| Q1 24 | $15.6M | $-35.6M |
| Q4 25 | — | 73.2% | ||
| Q3 25 | 25.0% | 71.4% | ||
| Q2 25 | — | 69.7% | ||
| Q1 25 | 28.0% | 71.8% | ||
| Q4 24 | 34.0% | 77.4% | ||
| Q3 24 | 21.8% | 73.1% | ||
| Q2 24 | — | 79.4% | ||
| Q1 24 | 33.3% | 71.3% |
| Q4 25 | — | -68.7% | ||
| Q3 25 | -9.9% | -24.2% | ||
| Q2 25 | — | -10.8% | ||
| Q1 25 | -25.7% | -26.2% | ||
| Q4 24 | -6.0% | -138.0% | ||
| Q3 24 | -46.9% | -21.6% | ||
| Q2 24 | — | -37.3% | ||
| Q1 24 | -2.5% | -42.7% |
| Q4 25 | — | -77.8% | ||
| Q3 25 | -32.1% | 14.5% | ||
| Q2 25 | — | -26.4% | ||
| Q1 25 | -42.0% | -21.8% | ||
| Q4 24 | -20.2% | -153.2% | ||
| Q3 24 | -65.7% | -38.1% | ||
| Q2 24 | — | 52.3% | ||
| Q1 24 | 43.8% | -41.8% |
| Q4 25 | — | $-9.22 | ||
| Q3 25 | $-0.29 | $-2.76 | ||
| Q2 25 | — | $-0.17 | ||
| Q1 25 | $-0.47 | $-0.24 | ||
| Q4 24 | $-0.25 | $-17.23 | ||
| Q3 24 | $-0.53 | $-4.74 | ||
| Q2 24 | — | $-0.33 | ||
| Q1 24 | $0.42 | $-0.40 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.9M | $95.0M |
| Total DebtLower is stronger | $136.0M | — |
| Stockholders' EquityBook value | $-10.5M | $-44.5M |
| Total Assets | $235.2M | $454.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $95.0M | ||
| Q3 25 | $18.9M | $106.7M | ||
| Q2 25 | — | $162.0M | ||
| Q1 25 | $5.4M | $176.3M | ||
| Q4 24 | $9.5M | $183.2M | ||
| Q3 24 | — | $142.1M | ||
| Q2 24 | — | $146.0M | ||
| Q1 24 | — | $127.1M |
| Q4 25 | — | — | ||
| Q3 25 | $136.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $124.9M | — | ||
| Q4 24 | $111.3M | — | ||
| Q3 24 | $106.3M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $97.1M | $512.1M |
| Q4 25 | — | $-44.5M | ||
| Q3 25 | $-10.5M | $-22.1M | ||
| Q2 25 | — | $-82.4M | ||
| Q1 25 | $2.2M | $-74.9M | ||
| Q4 24 | $15.4M | $-67.3M | ||
| Q3 24 | $-3.9M | $45.9M | ||
| Q2 24 | — | $66.6M | ||
| Q1 24 | $17.7M | $19.2M |
| Q4 25 | — | $454.7M | ||
| Q3 25 | $235.2M | $511.4M | ||
| Q2 25 | — | $604.2M | ||
| Q1 25 | $237.7M | $596.2M | ||
| Q4 24 | $255.4M | $607.8M | ||
| Q3 24 | $246.8M | $692.0M | ||
| Q2 24 | — | $703.8M | ||
| Q1 24 | $246.2M | $724.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 56.05× | — | ||
| Q4 24 | 7.20× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 5.49× | 26.69× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $-9.7M |
| Free Cash FlowOCF − Capex | $25.0K | $-12.0M |
| FCF MarginFCF / Revenue | 0.1% | -20.2% |
| Capex IntensityCapex / Revenue | 5.6% | 3.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-16.8M | $-42.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-9.7M | ||
| Q3 25 | $1.8M | $-6.0M | ||
| Q2 25 | — | $-11.7M | ||
| Q1 25 | $1.2M | $-3.1M | ||
| Q4 24 | $-6.1M | $-3.1M | ||
| Q3 24 | $-613.0K | $4.8M | ||
| Q2 24 | — | $-17.9M | ||
| Q1 24 | $-1.4M | $1.1M |
| Q4 25 | — | $-12.0M | ||
| Q3 25 | $25.0K | $-8.9M | ||
| Q2 25 | — | $-14.8M | ||
| Q1 25 | $-4.3M | $-6.9M | ||
| Q4 24 | $-8.6M | $-6.8M | ||
| Q3 24 | $-4.0M | $-230.0K | ||
| Q2 24 | — | $-22.9M | ||
| Q1 24 | $-7.8M | $-10.4M |
| Q4 25 | — | -20.2% | ||
| Q3 25 | 0.1% | -14.8% | ||
| Q2 25 | — | -24.9% | ||
| Q1 25 | -12.1% | -10.6% | ||
| Q4 24 | -26.3% | -9.2% | ||
| Q3 24 | -16.3% | -0.3% | ||
| Q2 24 | — | -28.7% | ||
| Q1 24 | -21.8% | -12.2% |
| Q4 25 | — | 3.9% | ||
| Q3 25 | 5.6% | 4.8% | ||
| Q2 25 | — | 5.3% | ||
| Q1 25 | 15.5% | 5.8% | ||
| Q4 24 | 7.5% | 5.0% | ||
| Q3 24 | 13.9% | 6.8% | ||
| Q2 24 | — | 6.2% | ||
| Q1 24 | 17.8% | 13.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | -0.69× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -0.43× | ||
| Q1 24 | -0.09× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
LPSN
| Hosted Services Business | $51.0M | 86% |
| Professional Services | $8.3M | 14% |
